William Richards
Corporate Officer/Principal bei 23ANDME HOLDING CO.
Vermögen: 343 959 $ am 31.03.2024
Profil
William Richards is currently the Vice President-Drug Discovery at 23andMe, Inc. and 23andMe Holding Co. He previously worked as the Executive Director-Research at Amgen, Inc. from 1996 to 2019.
Additionally, he served as the Chief Scientific Officer at Nura Bio, Inc. Dr. Richards holds a doctorate degree from Stony Brook University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.02.2024 | 646 540 ( 0,20% ) | 343 959 $ | 31.03.2024 |
Aktive Positionen von William Richards
| Unternehmen | Position | Beginn |
|---|---|---|
| 23ANDME HOLDING CO. | Corporate Officer/Principal | - |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01.01.2020 |
Ehemalige bekannte Positionen von William Richards
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01.01.2019 |
Nura Bio, Inc.
 Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von William Richards
| Stony Brook University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| 23ANDME HOLDING CO. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
Nura Bio, Inc.
Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
